Clinical Trial Update: Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma [NA]

View source ↗

Summary

Completed clinical trial evaluating intrahepatic arterial delivery of yttrium-90 glass microspheres for cholangiocarcinoma; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Y-90 glass microspheres (yttrium-90 glass microspheres)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Cholangiocarcinoma | NA | Status: COMPLETED | Results posted: 2016-10-19